IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of “Moderate Buy” by Analysts
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the sixteen analysts that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the […]
More Stories
Fortescue Ltd (OTCMKTS:FSUGY) Sees Large Growth in Short Interest
Fortescue Ltd (OTCMKTS:FSUGY – Get Free Report) saw a large growth in short interest in the month of December. As...
Mawson Gold Limited (OTCMKTS:MWSNF) Short Interest Update
Mawson Gold Limited (OTCMKTS:MWSNF – Get Free Report) was the recipient of a significant decline in short interest in the...
WaFd, Inc (NASDAQ:WAFD) Short Interest Up 26.8% in December
WaFd, Inc (NASDAQ:WAFD – Get Free Report) was the recipient of a large growth in short interest in the month...
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Sees Large Decline in Short Interest
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) saw a significant decrease in short interest in December. As of December...
BlackRock Taxable Municipal Bond Trust (NYSE:BBN) Short Interest Up 52.8% in December
BlackRock Taxable Municipal Bond Trust (NYSE:BBN – Get Free Report) saw a significant increase in short interest during the month...
How QR Code Scanners Help The Restaurant Industry?
The hotel sector is hoping that contactless ordering would help it recover in the aftermath of the epidemic as the...